{"id":"https://openalex.org/W4409410368","doi":"https://doi.org/10.1007/s12254-025-01028-5","title":"ESMO 2024: highlights in breast cancer","display_name":"ESMO 2024: highlights in breast cancer","publication_year":2025,"publication_date":"2025-04-14","ids":{"openalex":"https://openalex.org/W4409410368","doi":"https://doi.org/10.1007/s12254-025-01028-5"},"language":"en","primary_location":{"id":"doi:10.1007/s12254-025-01028-5","doi":"https://doi.org/10.1007/s12254-025-01028-5","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s12254-025-01028-5","pdf_url":"https://link.springer.com/content/pdf/10.1007/s12254-025-01028-5.pdf","source":{"id":"https://openalex.org/S185035959","display_name":"memo - Magazine of European Medical Oncology","issn_l":"1865-5041","issn":["1865-5041","1865-5076"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","poland-20","russia-white-list-3"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"memo - Magazine of European Medical Oncology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://link.springer.com/content/pdf/10.1007/s12254-025-01028-5.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5021299330","display_name":"Simon Udovica","orcid":"https://orcid.org/0000-0001-6490-4568","observed_orcids":["https://orcid.org/0000-0001-6490-4568"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Simon Udovica","raw_affiliation_strings":["1st Department of Medicine, Centre for Oncology and Haematology, Clinic Ottakring, Vienna, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1st Department of Medicine, Centre for Oncology and Haematology, Clinic Ottakring, Vienna, Austria","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060653243","display_name":"Muna Ferner","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Muna Ferner","raw_affiliation_strings":["1st Department of Medicine, Centre for Oncology and Haematology, Clinic Ottakring, Vienna, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1st Department of Medicine, Centre for Oncology and Haematology, Clinic Ottakring, Vienna, Austria","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063343570","display_name":"Maximilian Marhold","orcid":"https://orcid.org/0000-0001-8439-3312","observed_orcids":["https://orcid.org/0000-0001-8439-3312"]},"institutions":[{"id":"https://openalex.org/I76134821","display_name":"Medical University of Vienna","ror":"https://ror.org/05n3x4p02","country_code":"AT","type":"education","lineage":["https://openalex.org/I76134821"]}],"countries":["AT"],"is_corresponding":false,"raw_author_name":"Maximilian Marhold","raw_affiliation_strings":["Department of Medicine 1, Division of Oncology, Medical University of Vienna, Waehringer Guertel 18\u201320, 1090, Vienna, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine 1, Division of Oncology, Medical University of Vienna, Waehringer Guertel 18\u201320, 1090, Vienna, Austria","institution_ids":["https://openalex.org/I76134821"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041597976","display_name":"Kathrin Strasser\u2010Weippl","orcid":"https://orcid.org/0000-0003-3639-3232","observed_orcids":["https://orcid.org/0000-0003-3639-3232"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kathrin Strasser-Weippl","raw_affiliation_strings":["1st Department of Medicine, Centre for Oncology and Haematology, Clinic Ottakring, Vienna, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1st Department of Medicine, Centre for Oncology and Haematology, Clinic Ottakring, Vienna, Austria","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5041466806","display_name":"Rupert Bartsch","orcid":"https://orcid.org/0000-0002-4384-6917","observed_orcids":["https://orcid.org/0000-0002-4384-6917"]},"institutions":[{"id":"https://openalex.org/I76134821","display_name":"Medical University of Vienna","ror":"https://ror.org/05n3x4p02","country_code":"AT","type":"education","lineage":["https://openalex.org/I76134821"]}],"countries":["AT"],"is_corresponding":true,"raw_author_name":"Rupert Bartsch","raw_affiliation_strings":["Department of Medicine 1, Division of Oncology, Medical University of Vienna, Waehringer Guertel 18\u201320, 1090, Vienna, Austria"],"raw_orcid":"https://orcid.org/0000-0002-4384-6917","affiliations":[{"raw_affiliation_string":"Department of Medicine 1, Division of Oncology, Medical University of Vienna, Waehringer Guertel 18\u201320, 1090, Vienna, Austria","institution_ids":["https://openalex.org/I76134821"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5041466806"],"corresponding_institution_ids":["https://openalex.org/I76134821"],"apc_list":{"value":4790,"currency":"USD","value_usd":4790},"apc_paid":{"value":4790,"currency":"USD","value_usd":4790},"fwci":0.2805,"has_fulltext":true,"cited_by_count":1,"citation_normalized_percentile":{"value":0.42925487,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":93},"biblio":{"volume":"18","issue":"2","first_page":"75","last_page":"79"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.9150000214576721,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.9150000214576721,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.08049999922513962,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.9729999899864197},{"id":"https://openalex.org/keywords/early-breast-cancer","display_name":"early breast cancer","score":0.8370000123977661},{"id":"https://openalex.org/keywords/cdk4-6-inhibitors","display_name":"CDK4/6 inhibitors","score":0.8560000061988831},{"id":"https://openalex.org/keywords/natalee-trial","display_name":"NATALEE trial","score":0.8709999918937683},{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":0.9039999842643738},{"id":"https://openalex.org/keywords/keynote-522","display_name":"KEYNOTE-522","score":0.9729999899864197},{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":0.9670000076293945},{"id":"https://openalex.org/keywords/her2-positive-breast-cancer","display_name":"HER2-positive breast cancer","score":0.972000002861023},{"id":"https://openalex.org/keywords/trastuzumab","display_name":"trastuzumab","score":0.8579999804496765},{"id":"https://openalex.org/keywords/pertuzumab","display_name":"pertuzumab","score":1.0},{"id":"https://openalex.org/keywords/ovarian-function-suppression","display_name":"ovarian suppression","score":0.8880000114440918},{"id":"https://openalex.org/keywords/endocrine-therapy","display_name":"endocrine therapy","score":0.8379999995231628},{"id":"https://openalex.org/keywords/hera-trial","display_name":"HERA trial","score":0.9509999752044678},{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":0.9629999995231628},{"id":"https://openalex.org/keywords/trastuzumab-deruxtecan","display_name":"trastuzumab deruxtecan","score":0.996999979019165},{"id":"https://openalex.org/keywords/patritumab-deruxtecan","display_name":"patritumab deruxtecan","score":0.9620000123977661},{"id":"https://openalex.org/keywords/her3","display_name":"HER3","score":0.7450000047683716},{"id":"https://openalex.org/keywords/brain-metastases","display_name":"brain metastases","score":0.8420000076293945},{"id":"https://openalex.org/keywords/metastatic-triple-negative-breast-cancer","display_name":"metastatic triple-negative breast cancer","score":0.8199999928474426},{"id":"https://openalex.org/keywords/pi3k-akt-mtor-pathway","display_name":"PI3K/AKT/mTOR pathway","score":0.8569999933242798}],"concepts":[{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.616619348526001},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.49862051010131836},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4410494267940521},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4100220203399658},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.32538801431655884}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1007/s12254-025-01028-5","doi":"https://doi.org/10.1007/s12254-025-01028-5","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s12254-025-01028-5","pdf_url":"https://link.springer.com/content/pdf/10.1007/s12254-025-01028-5.pdf","source":{"id":"https://openalex.org/S185035959","display_name":"memo - Magazine of European Medical Oncology","issn_l":"1865-5041","issn":["1865-5041","1865-5076"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","poland-20","russia-white-list-3"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"memo - Magazine of European Medical Oncology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1007/s12254-025-01028-5","doi":"https://doi.org/10.1007/s12254-025-01028-5","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s12254-025-01028-5","pdf_url":"https://link.springer.com/content/pdf/10.1007/s12254-025-01028-5.pdf","source":{"id":"https://openalex.org/S185035959","display_name":"memo - Magazine of European Medical Oncology","issn_l":"1865-5041","issn":["1865-5041","1865-5076"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","poland-20","russia-white-list-3"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"memo - Magazine of European Medical Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320321691","display_name":"Universit\u00e4t Wien","ror":"https://ror.org/03prydq77"},{"id":"https://openalex.org/F4320323437","display_name":"Medizinische Universit\u00e4t Wien","ror":"https://ror.org/05n3x4p02"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4409410368.pdf","grobid_xml":"https://content.openalex.org/works/W4409410368.grobid-xml"},"referenced_works_count":29,"referenced_works":["https://openalex.org/W2121518344","https://openalex.org/W2130771251","https://openalex.org/W2149908785","https://openalex.org/W2588881638","https://openalex.org/W3017377697","https://openalex.org/W3020482066","https://openalex.org/W4210957314","https://openalex.org/W4281619692","https://openalex.org/W4290673816","https://openalex.org/W4376131458","https://openalex.org/W4378801565","https://openalex.org/W4387396499","https://openalex.org/W4387533767","https://openalex.org/W4390706369","https://openalex.org/W4399150586","https://openalex.org/W4399605571","https://openalex.org/W4402282294","https://openalex.org/W4402514945","https://openalex.org/W4402551965","https://openalex.org/W4402558540","https://openalex.org/W4402558548","https://openalex.org/W4402561243","https://openalex.org/W4402561371","https://openalex.org/W4402561415","https://openalex.org/W4402561497","https://openalex.org/W4402561814","https://openalex.org/W4402561880","https://openalex.org/W4402561911","https://openalex.org/W4402565486"],"related_works":["https://openalex.org/W4229042453","https://openalex.org/W7127155302","https://openalex.org/W6888389625","https://openalex.org/W4205461871","https://openalex.org/W4410561697","https://openalex.org/W3125030632","https://openalex.org/W4220721766","https://openalex.org/W4313207902","https://openalex.org/W7139079215","https://openalex.org/W6920839699"],"abstract_inverted_index":{"Summary":[0],"Several":[1],"clinically":[2],"relevant":[3],"abstracts":[4],"in":[5,42,68,101,114,121,147,165,185,220,253,258],"the":[6,15,19,28,34,76,102,107,122,141,180,205,214,250,259],"field":[7],"of":[8,18,36,53,58,97,109,124,134,143,179,216,249],"breast":[9,46,230],"cancer":[10,47,231],"(BC)":[11],"were":[12],"presented":[13],"during":[14],"2024":[16],"congress":[17],"European":[20],"Society":[21],"for":[22,207],"Medical":[23],"Oncology":[24],"(ESMO).":[25],"Updates":[26],"from":[27,138],"phase":[29,77,167,172],"3":[30],"NATALEE":[31],"trial":[32,80,105,175],"supported":[33],"role":[35,215],"cyclin-dependent":[37],"kinase":[38],"(CDK)":[39],"4/6":[40,218],"inhibitors":[41,219],"early-stage":[43,69,74],"hormone-receptor":[44],"(HR)-positive/HER2-negative":[45],"with":[48,66,85,90,117,152,188,222,227],"intermediate":[49],"to":[50],"high":[51,158],"risk":[52],"recurrence,":[54],"while":[55,209],"an":[56,61],"update":[57],"KEYNOTE-522":[59],"reported":[60,81],"overall":[62],"survival":[63],"(OS)":[64],"benefit":[65],"pembrolizumab":[67],"triple-negative":[70,229],"disease.":[71,191,224],"In":[72,225],"HER2-positive":[73,149],"BC,":[75],"2":[78,173],"WSG-TP-II":[79],"excellent":[82],"long-term":[83],"outcomes":[84],"de-escalated":[86],"neoadjuvant":[87],"chemotherapy":[88,208],"combined":[89],"trastuzumab":[91,144],"and":[92,161,196,201,239],"pertuzumab.":[93],"A":[94],"retrospective":[95],"analysis":[96],"endocrine":[98],"treatment":[99],"strategies":[100],"pivotal":[103],"HERA":[104],"emphasized":[106],"importance":[108],"ovarian":[110],"function":[111],"suppression":[112],"(OFS)":[113],"premenopausal":[115],"patients":[116,151,187,221,226],"HR-positive/HER2-positive":[118,195,223],"disease,":[119],"even":[120],"presence":[123],"HER2-directed":[125],"treatments.":[126],"Antibody\u2013drug":[127],"conjugates":[128],"(ADCs)":[129],"remain":[130],"a":[131],"key":[132],"focus":[133],"scientific":[135],"interest.":[136],"Results":[137],"DESTINY-Breast12":[139],"support":[140],"use":[142],"deruxtecan":[145,184],"(T-DXd)":[146],"metastatic":[148,189,228,254],"BC":[150,198],"active":[153],"brain":[154],"metastases":[155],"(BM),":[156],"showing":[157],"response":[159],"rates":[160],"prolonged":[162],"disease":[163],"control":[164],"this":[166],"3b/4":[168],"study.":[169],"The":[170],"single-arm":[171],"ICARUS-Breast01":[174],"demonstrated":[176],"promising":[177,242],"results":[178],"HER3-directed":[181],"ADC":[182],"patritumab":[183],"pretreated":[186],"luminal":[190],"Biological":[192],"differences":[193],"between":[194],"HR-negative/HER2-positive":[197],"are":[199],"evident,":[200],"DETECT":[202],"V":[203],"questions":[204],"need":[206],"corroborating":[210],"previous":[211],"data":[212],"supporting":[213],"CDK":[217],"(TNBC),":[232],"bispecific":[233],"antibodies":[234],"co-targeting":[235],"PD\u20111":[236],"or":[237],"PD-L1":[238],"VEGF":[240],"showed":[241],"results.":[243],"Despite":[244],"sound":[245],"clinical":[246],"rationale,":[247],"inhibition":[248],"PI3K/AKT/mTOR":[251],"pathway":[252],"TNBC":[255],"remained":[256],"unsuccessful":[257],"CAPItello-290":[260],"trial.":[261]},"counts_by_year":[{"year":2025,"cited_by_count":1}],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2025-04-14T00:00:00"}